The top 20 pharma companies in Portugal ranked by sales and market share for the year leading up to March 2018. MSD leads the way with EUR 148 million…

Experienced country manager, João Madeira, introduces Mylan’s new vision to be a global healthcare company serving patients across the world with…

After a series of recent acquisitions, developing a diverse portfolio comprising four business areas; including OTC and branded prescription…

Artur Chabowski, president of Mabion, a pioneer Polish biotech player, discusses the historic partnership of their product, MabionCD20 with Mylan for…

Jacek Glinka, president of Mylan Europe, and Tomasz Buczek, country manager of Mylan Poland, discuss the intricate dynamics of the European and Polish…

Janis Kalejs, country manager Baltics at Mylan, discloses the strategies he has used to successfully lead his affiliate through corporate changes and…

Milos Davidovic, Mylan's country manager responsible for Serbia, Slovenia, Macedonia, and Montenegro, reveals the made-to-measure market approach that…

Yavor Kostov, country manager at Mylan in Bulgaria, discloses his strategies to successfully lead an affiliate through corporate changes and explains…

Mylan Hungary's Tamas Uri discusses transitioning into both a branded and generic business dedicated company, Mylan's expansion in Hungary, and how…

The general manager of one of the world's largest API manufacturers recalls the recent acquisition of Abbott by Mylan and the processes which he has…

Javier Anitua, Managing Director of Mylan Spain, discusses the preservation of Spain’s pharmacy model, preventive solutions for pharmacists, and the…

João Madeira, General Manager of Mylan Portugal provides an overview of the state of generics in Portugal today, discussing structural issues related…